“People, I think, have started looking outside the box when it comes to health care. And they’re turning more to wellness and functional medicine, more holistic ways of looking at their health than just going to the doctor, picking up prescriptions.”

Considering weight-loss supplements? Doctors are raising red flags about their safety.

A groundbreaking study from Cleveland Clinic reveals that bariatric surgery offers significant long-term health benefits over GLP-1 medications for weight loss.

Recent research from Cleveland Clinic reveals that variations in the Neurobeachin gene may significantly influence weight loss success with GLP-1 medications.

Some of the more than a dozen states that cover the high cost of GLP-1 drugs like Wegovy, Ozempic and Zepbound through Medicaid or state employee insurance programs are scrambling to lessen the budgetary squeeze from fast-rising costs.

While West Virginia's employee health insurance program covers drugs like Ozempic for people with type 2 diabetes, officials decided to indefinitely pause covering their use for weight loss patients because of the cost.

The federal government is phasing out off-brand copies of two blockbuster drugs used to treat obesity and diabetes.

Use of diabetes and obesity medications such as Ozempic, Wegovy and other so-called GLP-1 drugs has soared among teens and young adults.